Across TCGA pan-cancer cohorts, LINC01907 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated LINC01907 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LINC01907 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01907 expression acts as an unfavorable survival marker, although some lineages such as COAD and UVM show a favorable association.
UCEC, COAD, and UVM are the cancer types where LINC01907 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.